Company intelligence / Profile preview

PharmaResearch

Not specified, Gangwon-do, South Korea

Ownership: Private
Development stage: Commercial

Overview

PharmaResearch is a global leader in regenerative medicine, best known for its patented DOT™ PDRN/PN technology. Its flagship product, REJURAN®, is a widely recognized skin booster sold in over 30 countries. The company has expanded into botulinum toxin products, fillers, medical devices, derma cosmetics, and non-surgical orthopedic solutions. It continues to innovate with new patents and clinical programs focused on aesthetics and tissue regeneration[1][2][3][4].

Therapeutic areas: OtherDermatologyRheumatology
Modalities: Polynucleotides (PDRN, PN)Botulinum toxin preparationsSmall molecules (general pharmaceuticals)
Industry: Biotech

Drug pipeline

4 assets

Rejuvenex Cream

Unknown

3 more assets in the full pipeline.

Request access →

Partnerships

CVC Capital Partners—major investment partnership with European private equity firm CVC securing ₩200 billion (~$150M USD) investment for growth[3].Collaborations with domestic/international research institutions mentioned but not individually named[2].

Beyond the preview

Go deeper on PharmaResearch.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PharmaResearch.

Explore the full profile